Diabetes and PCOS: Understanding the Insulin Resistance Link
How Polycystic Ovary Syndrome and diabetes share the same underlying driver—insulin resistance—and practical steps to restore balance.

Polycystic Ovary Syndrome (PCOS) is one of the most common hormonal conditions affecting women in Pakistan. Many women diagnosed with PCOS are surprised when their doctor orders a Fasting Glucose or HbA1c test and begins discussing diabetes risk.
PCOS and Type 2 diabetes are deeply connected because they share the exact same root mechanism: insulin resistance.
How Insulin Resistance Drives PCOS Symptoms
Up to 70% of women with PCOS have underlying insulin resistance. Here is how elevated insulin affects female reproductive hormones:
- 1Excess Insulin Triggers Male Hormones: High levels of circulating insulin signal the ovaries to produce excess androgen hormones (such as testosterone).
- 2Hormonal Symptoms Emerge: Excess androgens interrupt normal ovulation (causing irregular or missed periods), acne, facial hair growth (hirsutism), and scalp hair thinning.
- 3Weight Gain Around Abdomen: High insulin makes it easy for the body to store fat around the midsection and difficult to lose weight.
- 4Increased Diabetes Risk: Over time, persistent insulin resistance increases the risk of developing prediabetes and Type 2 diabetes by age 40.
| PCOS Challenge | Insulin Resistance Link | Practical Management Strategy |
|---|---|---|
| Irregular Periods / Anovulation | High insulin blocks egg maturation | Low-GI meal planning + Metformin therapy |
| Abdominal Weight Gain | Insulin locks fat in storage tissue | Strength training + 15-min post-meal walking |
| High Carb Cravings | Rapid glucose crashes from over-insulin | Pairing all carbs with protein and fiber |
How Much Does PCOS Really Raise Diabetes Risk?
The numbers are worth knowing precisely rather than vaguely. Endocrine Society research (opens in a new tab) found women with PCOS were about four times more likely to develop type 2 diabetes than women without it, and were diagnosed at a notably younger average age — 31 years old in that research, well before diabetes typically appears in the general population. Within the PCOS population itself, the Endocrine Society's clinical practice guideline (opens in a new tab) notes that 50 to 70% of women with PCOS have some degree of measurable insulin resistance.
Why an OGTT, Not Just a Fasting Sugar Test
A single fasting blood sugar reading can look completely normal in PCOS even when insulin resistance is well underway, because the body often compensates by producing extra insulin — keeping glucose numbers in range at the cost of driving up androgen hormones and PCOS symptoms. This is exactly why the Endocrine Society guideline (opens in a new tab) recommends a 75g oral glucose tolerance test over HbA1c or fasting glucose alone for women with PCOS, repeated every 3 to 5 years, or sooner if weight changes substantially or symptoms of diabetes appear. An OGTT catches the impaired response an ordinary fasting test can miss.
Doctors frequently prescribe Metformin to women with PCOS even if they do not have diabetes. By cleaning the 'rusty locks' on cells, Metformin lowers circulating insulin levels, which reduces androgen production, helps restore regular period cycles, and improves fertility.
A Kinder Approach to Weight and PCOS
PCOS makes weight management genuinely harder, not because of a lack of effort but because high insulin actively encourages fat storage and fuels cravings — this is biology working against you, not a discipline problem. The encouraging side of this is that the threshold for meaningful improvement is lower than most women expect: even a 5 to 10% reduction in body weight has been shown to improve ovulation, menstrual regularity, and insulin sensitivity in PCOS, without needing to reach any particular target weight.
Reversing the Cycle
Managing PCOS and preventing Type 2 diabetes rely on the same lifestyle pillars: strength training to build muscle glucose storage, eating low-glycemic high-fiber Pakistani meals, prioritizing 7 to 8 hours of sleep, and reducing stress.
PCOS, Fertility, and Diabetes Are More Connected Than They Seem
Many women first encounter PCOS while trying to conceive, since irregular ovulation is one of its hallmark effects. What is less commonly explained is that the same insulin resistance driving ovulation trouble also raises the risk of gestational diabetes if and when pregnancy happens — so a PCOS diagnosis before pregnancy is genuinely useful information for your obstetrician later, not just for a fertility specialist now.
This is also why lifestyle changes for PCOS and lifestyle changes for diabetes prevention are, in practice, the same set of habits. There is no separate PCOS diet and diabetes diet to juggle — consistent meals, regular movement, and adequate sleep address the shared root cause from both directions at once.
“PCOS and diabetes are connected through insulin resistance—treating the root cause restores balance to both.”
Log your daily meals, activity, and symptoms in Diatic to build a clear picture for your endocrinologist.
Frequently asked questions
Does having PCOS mean I will definitely get Type 2 diabetes?
No. Having PCOS increases your risk, but it is not inevitable. Taking proactive steps early to manage insulin resistance through nutrition and physical activity dramatically lowers your future risk.
How often should women with PCOS get tested for prediabetes?
Women with PCOS should get an Oral Glucose Tolerance Test (OGTT) or HbA1c test screened at diagnosis and repeated every 1 to 2 years.
Should every woman with PCOS take Metformin?
Not necessarily. Metformin is commonly prescribed when insulin resistance, irregular cycles, or fertility concerns are present, but treatment is individualized. Some women manage PCOS well with lifestyle changes alone; your gynecologist or endocrinologist will weigh your specific symptoms and test results.
If I have PCOS, does that raise my risk during a future pregnancy too?
Yes, PCOS is a recognized risk factor for gestational diabetes, since the same underlying insulin resistance carries into pregnancy. If you become pregnant, mention your PCOS history early so your obstetrician can decide whether earlier screening makes sense for you — see our guide on [gestational diabetes explained](/blog/gestational-diabetes-explained-causes-targets-vs-type-2) for what that testing involves.
Sources
- American Diabetes Association (ADA) (opens in a new tab)
- American College of Obstetricians and Gynecologists (ACOG) (opens in a new tab)
- Centers for Disease Control and Prevention (CDC) (opens in a new tab)
- PCOS Society of Pakistan / Society of Obstetricians and Gynaecologists of Pakistan (SOGP) (opens in a new tab)
- Diabetes UK (opens in a new tab)
- Muka et al., Diabetologia (Rotterdam Study) (opens in a new tab)
- Baig & Karim, Journal of the British Menopause Society (Karachi population study) (opens in a new tab)
- American Diabetes Association, Standards of Care in Diabetes 2026 (Section 4) (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (opens in a new tab)
- El Khoudary et al., Circulation (American Heart Association Scientific Statement, 2020) (opens in a new tab)
- Peters, Huxley & Woodward, Diabetologia (2014 meta-analysis) (opens in a new tab)
- Vestergaard, Osteoporosis International (2007 meta-analysis) (opens in a new tab)
- Lowe et al., Journal of Health, Population and Nutrition (rural Pakistan study) (opens in a new tab)
- Kim et al., Menopause (Diabetes Prevention Program) (opens in a new tab)
- Greendale et al., JCI Insight (Study of Women's Health Across the Nation) (opens in a new tab)
- Margolis et al., Diabetologia (Women's Health Initiative Hormone Trial) (opens in a new tab)
- American Diabetes Association, Standards of Care in Diabetes 2026 (Section 2) (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (opens in a new tab)
- Journal of Clinical Endocrinology & Metabolism (Thurston et al., SWAN, 2012) (opens in a new tab)
- JAMA Network Open (Hedderson et al., SWAN, 2024) (opens in a new tab)
- The Menopause Society (2023 Nonhormone Therapy Position Statement) (opens in a new tab)
- National Center for Complementary and Integrative Health (NCCIH) (opens in a new tab)
- Journal of Ayub Medical College Abbottabad (rural Lahore menopause study) (opens in a new tab)
- NHS (opens in a new tab)
- Anagnostis et al., European Journal of Endocrinology (2019 systematic review and meta-analysis) (opens in a new tab)
- Maturitas / PubMed (2023 systematic review and meta-analysis of long-term cardiometabolic disease after premature or early menopause) (opens in a new tab)
- ESHRE / ASRM Evidence-Based Guideline: Premature Ovarian Insufficiency (Human Reproduction Open, 2024) (opens in a new tab)
- Dorman et al., Diabetes (Familial Autoimmune and Diabetes Study) (opens in a new tab)
- Yarde et al., Human Reproduction (OVADIA study, 2015) (opens in a new tab)
- Hysterectomy and Oophorectomy in Reproductive Age: A Cross-Sectional Study from a Tertiary Care Hospital (Dow Medical College, Karachi) (opens in a new tab)
- American Diabetes Association, Standards of Care in Diabetes 2026 (Section 15) (opens in a new tab)
- Fetal anomalies in gestational diabetes mellitus and pre-conceptional HbA1c (PMC) (opens in a new tab)
- ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum (opens in a new tab)
- Endocrine Society Clinical Practice Guideline: Diagnosis and Treatment of Polycystic Ovary Syndrome (opens in a new tab)
- Endocrine Society (2017 research summary) (opens in a new tab)
- BioCycle Study, Journal of Clinical Endocrinology & Metabolism (opens in a new tab)
- npj Digital Medicine (continuous glucose monitor study across the menstrual cycle) (opens in a new tab)
